Showing results 1 to 20 of 34
next >
| Issue Date | Title | Author(s) |
| 1-Jul-2021 | 50-gene risk profiles in peripheral blood predict COVID-19 outcomes: A retrospective, multicenter cohort study | Juan Guardela, BM; Sun, J; Zhang, T; Xu, B; Balnis, J, et al |
| 26-Mar-2020 | A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose of a novel inhaled αvβ6 integrin inhibitor | Maher, TM; Simpson, JK; Porter, JC; Wilson, FJ; Chan, R, et al |
| 3-Apr-2020 | Bacterial burden in the lower airways predicts disease progression in idiopathic pulmonary fibrosis and is independent of radiological disease extent | Invernizzi, R; Barnett, J; Rawal, B; Nair, A; Ghai, P, et al |
| 9-Mar-2021 | Blood transcriptomic predicts progression of pulmonary fibrosis and associates natural killer cells. | Huang, Y; Oldham, JM; Ma, S-F; Unterman, A; Liao, S-Y, et al |
| 28-Aug-2020 | Bronchoalveolar lavage is safe and well tolerated in individuals with idiopathic pulmonary fibrosis: an analysis of the PROFILE study | Molyneaux, PL; Smith, JJ; Saunders, P; Chua, F; Wells, AU, et al |
| 5-Jan-2022 | Candidate role for toll-like receptor 3 L412F polymorphism and infection in acute exacerbation of idiopathic pulmonary fibrosis | McElroy, AN; Invernizzi, R; Laskowska, JW; O'Neill, A; Doroudian, M, et al |
| 7-Jan-2022 | Common idiopathic pulmonary fibrosis risk variants are associated with hypersensitivity pneumonitis | Furusawa, H; Peljto, AL; Walts, AD; Cardwell, J; Molyneaux, PL, et al |
| 15-Jun-2022 | CYFRA 21-1 predicts progression in IPF: a prospective longitudinal analysis of the PROFILE cohort | Molyneaux, PL; Fahy, WA; Byrne, AJ; Braybrooke, R; Saunders, P, et al |
| 1-Apr-2020 | Defining genetic risk factors for scleroderma-associated interstitial lung disease : IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease | Stock, CJW; De Lauretis, A; Visca, D; Daccord, C; Kokosi, M, et al |
| 15-Oct-2021 | DNA methylome alterations are associated with airway macrophage differentiation and phenotype during lung fibrosis. | McErlean, P; Bell, CG; Hewitt, RJ; Busharat, Z; Ogger, PP, et al |
| 2021 | Enhanced IL-1β Release Following NLRP3 and AIM2 Inflammasome Stimulation Is Linked to mtROS in Airway Macrophages in Pulmonary Fibrosis. | Trachalaki, A; Tsitoura, E; Mastrodimou, S; Invernizzi, R; Vasarmidi, E, et al |
| 1-Mar-2020 | Genome-wide association study of susceptibility to idiopathic pulmonary fibrosis | Allen, RJ; Guillen-Guio, B; Oldham, JM; Ma, S-F; Dressen, A, et al |
| 1-Oct-2022 | Genome-wide enrichment of TERT rare variants in Idiopathic Pulmonary Fibrosis patients of Latino ancestry | Zhang, D; Povysil, G; Newton, CA; Maher, TM; Molyneaux, PL, et al |
| 1-Mar-2022 | Immuno-proteomic profiling reveals aberrant immune cell regulation in the airways of individuals with ongoing post-COVD-19 respiratory disease | Vijayakumar, B; Boustani, K; Ogger, P; Papadaki, A; Tonkin, J, et al |
| 15-Sep-2020 | Interaction between the promoter MUC5B polymorphism and mucin expression: is there a difference according to ILD subtype? | Stock, CJ; Conti, C; Montero-Fernandez, Á; Caramori, G; Molyneaux, PL, et al |
| 11-Jul-2022 | Interstitial lung disease incidence and mortality in the United Kingdom and the European Union: an observational study, 2001-2017 | Salciccioli, J; Marshall, D; Goodall, R; Crowley, C; Shalhoub, J, et al |
| - | Lung function trajectory in progressive fibrosing interstitial lung disease | Oldham, JM; Lee, CT; Wu, Z; Bowman, WS; Pugashetti, JV, et al |
| 1-Nov-2019 | Modelling forced vital capacity in idiopathic pulmonary fibrosis: optimising trial design. | Santermans, E; Ford, P; Kreuter, M; Verbruggen, N; Meyvisch, P, et al |
| 1-Jul-2021 | Monocyte count as a prognostic biomarker in patients with idiopathic pulmonary fibrosis | Kreuter, M; Lee, JS; Tzouvelekis, A; Oldham, JM; Molyneaux, PL, et al |
| 2-Oct-2020 | Outcome of hospitalization for COVID-19 in patients with interstitial lung disease: an international multicenter study. | Drake, TM; Docherty, AB; Harrison, EM; Quint, JK; Adamali, H, et al |